Announcements Trials
Browse Landscape

Status

Completed 16Unknown 3Recruiting 2Active not recruiting 2Withdrawn 1Not yet recruiting 1

Sponsor Class

INDUSTRY 2

Study Type

Observational 2

Sponsor

Cancer Type

Head & Neck 2

Conditions

Breast Neoplasms 1780Neoplasms 1500Carcinoma, Non-Small-Cell Lung 1045Prostatic Neoplasms 958Colorectal Neoplasms 882Lung Neoplasms 803Pancreatic Neoplasms 573Carcinoma, Hepatocellular 543Leukemia, Myeloid, Acute 541Stomach Neoplasms 513Ovarian Neoplasms 508Neoplasm Metastasis 499Multiple Myeloma 494Recurrence 412Melanoma 387Squamous Cell Carcinoma of Head and Neck 370Brain Neoplasms 362Uterine Cervical Neoplasms 361Head and Neck Neoplasms 356Esophageal Neoplasms 312Precursor Cell Lymphoblastic Leukemia-Lymphoma 310Lymphoma 306Endometrial Neoplasms 305Triple Negative Breast Neoplasms 299Glioblastoma 299Rectal Neoplasms 282Sarcoma 266Urinary Bladder Neoplasms 264Hematologic Neoplasms 264Colonic Neoplasms 255

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Hyperplasia × Clear all
NCT04622462 2024-11-07

Early Prediction of Oral Cancer by S100A7 Immunohistochemistry Signature-based Assessment

Proteocyte Diagnostics Inc.

Recruiting
500 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Disease, Erythroplasia, Hyperplasia, Leukoplakia, Mouth Neoplasms, Keratoderma, Palmoplantar, Epidermolytic

NCT05853783 2024-11-07

Evaluation of Oral Potentially Malignant Disorders (OPMDs) with STRATICYTEâ„¢

Proteocyte Diagnostics Inc.

Recruiting
180 enrolled
Head & Neck

Disease, Erythroplasia, Hyperplasia, Leukoplakia, Mouth Diseases, Keratoderma, Palmoplantar, Epidermolytic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡